Ayala Pharmaceuticals Inc. (ADXS)
OTCMKTS: ADXS · Delayed Price · USD
0.646
+0.044 (7.40%)
Apr 17, 2024, 10:56 AM EDT - Market closed
Ayala Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 25.21 | 41.61 | 25.18 | 16.73 | 44.14 | 23.9 | 112.75 | 66.56 | 17.61 | 20.55 | Upgrade
|
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 46.4 | 39.34 | 45.59 | 0 | 0 | Upgrade
|
Cash & Cash Equivalents | 25.21 | 41.61 | 25.18 | 16.73 | 44.14 | 70.3 | 152.09 | 112.16 | 17.61 | 20.55 | Upgrade
|
Cash Growth | -39.42% | 65.28% | 50.54% | -62.11% | -37.21% | -53.78% | 35.60% | 537.00% | -14.33% | 8858547.41% | Upgrade
|
Receivables | 0 | 0.68 | 0.47 | 0.47 | 0 | 4.45 | 2.63 | 1.75 | 1.73 | 0 | Upgrade
|
Inventory | 0 | -0.68 | 1.34 | 0.08 | 0 | 0 | 5.1 | 1.09 | 1.15 | 0 | Upgrade
|
Other Current Assets | 0.55 | 1.64 | 0.87 | 0.42 | 6.32 | 6.49 | 0.05 | 0.02 | 0.01 | 0.26 | Upgrade
|
Total Current Assets | 25.76 | 43.26 | 27.85 | 17.69 | 50.47 | 81.24 | 159.88 | 115.01 | 20.49 | 20.81 | Upgrade
|
Property, Plant & Equipment | 0.05 | 0.16 | 7.23 | 1.42 | 6.68 | 7.11 | 4.39 | 1.09 | 0.08 | 0.08 | Upgrade
|
Intangible Assets | 0.11 | 3.35 | 3.26 | 0 | 4.84 | 4.86 | 4.33 | 3.36 | 2.77 | 2.53 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.01 | 0.18 | 0.94 | 0.28 | 0.43 | 0.45 | 0.15 | 0.04 | 0.17 | Upgrade
|
Total Long-Term Assets | 0.17 | 3.52 | 10.68 | 2.36 | 11.8 | 12.4 | 9.17 | 4.59 | 2.88 | 2.78 | Upgrade
|
Total Assets | 25.93 | 46.78 | 38.53 | 20.05 | 62.27 | 93.64 | 169.04 | 119.61 | 23.38 | 23.59 | Upgrade
|
Accounts Payable | 0.02 | 2.26 | 1.08 | 2.92 | 9.31 | 7.93 | 3.82 | 1.7 | 1.53 | 3.84 | Upgrade
|
Deferred Revenue | 0 | 0.67 | 0.17 | 0 | 4.48 | 7 | 15.02 | 0 | 0 | 0 | Upgrade
|
Current Debt | 0.01 | 0.03 | 0.96 | 0 | 2.53 | 5.89 | 8.81 | 0.03 | 0.06 | 0.23 | Upgrade
|
Other Current Liabilities | 2.27 | 4.93 | 1.08 | 2.38 | 6.57 | 0.05 | 0.06 | 2.19 | 1.12 | 0.87 | Upgrade
|
Total Current Liabilities | 2.3 | 7.88 | 3.29 | 5.3 | 22.87 | 20.86 | 27.71 | 3.92 | 2.72 | 4.94 | Upgrade
|
Long-Term Debt | 0 | 0.01 | 5.06 | 0.3 | 0 | 0 | 325.16 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Liabilities | 0 | 0 | 0 | 0 | 15.34 | 18.52 | -303.12 | 0.09 | 0.03 | 0.65 | Upgrade
|
Total Long-Term Liabilities | 0 | 0.01 | 5.06 | 0.3 | 15.34 | 18.52 | 22.04 | 0.09 | 0.03 | 0.65 | Upgrade
|
Total Liabilities | 2.3 | 7.89 | 8.35 | 5.6 | 38.22 | 39.38 | 49.74 | 4.01 | 2.75 | 5.58 | Upgrade
|
Total Debt | 0.01 | 0.04 | 6.02 | 0.3 | 0 | 0 | 325.16 | 0.03 | 0.06 | 0.23 | Upgrade
|
Debt Growth | -70.00% | -99.34% | 1912.37% | - | - | - | 1100309.49% | -53.01% | -72.18% | -52.64% | Upgrade
|
Common Stock | 0 | 0.15 | 0.08 | 0.09 | 0.07 | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | Upgrade
|
Retained Earnings | -442.96 | -428.6 | -410.74 | -40.74 | -367.66 | -301.14 | -207.71 | -134.05 | -86.99 | -70.47 | Upgrade
|
Comprehensive Income | 0 | 0 | 0 | 0 | 0 | -1.21 | -0.43 | -0.14 | -0.26 | -0.23 | Upgrade
|
Shareholders' Equity | 23.63 | 38.89 | 30.18 | 14.45 | 24.05 | 54.26 | 119.3 | 115.6 | 20.63 | 18 | Upgrade
|
Total Liabilities and Equity | 25.93 | 46.78 | 38.53 | 20.05 | 62.27 | 93.64 | 169.04 | 119.61 | 23.38 | 23.59 | Upgrade
|
Net Cash / Debt | 25.2 | 41.57 | 19.16 | 16.43 | 44.14 | 70.3 | -173.07 | 112.13 | 17.54 | 20.33 | Upgrade
|
Net Cash / Debt Growth | -39.39% | 116.97% | 16.65% | -62.79% | -37.21% | - | - | 539.12% | -13.69% | - | Upgrade
|
Net Cash Per Share | 13.85 | 25.76 | 25.13 | 86.41 | 1028.09 | 2081.49 | -5866.86 | 4800.97 | 1230.72 | 4867.35 | Upgrade
|
Working Capital | 23.46 | 35.38 | 24.56 | 12.39 | 27.59 | 60.38 | 132.17 | 111.1 | 17.78 | 15.87 | Upgrade
|
Book Value Per Share | 12.99 | 24.10 | 39.58 | 76.03 | 560.17 | 1606.61 | 4044.14 | 4949.64 | 1447.21 | 4310.86 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.